Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs

Summary by The Huntsville Item
RAHWAY, N.J.--(BUSINESS WIRE)--Mar 18, 2026-

2 Articles

The Huntsville ItemThe Huntsville Item
Reposted by
HealthTech HotSpotHealthTech HotSpot
Lean Left

FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs

RAHWAY, N.J.--(BUSINESS WIRE)--Mar 18, 2026-

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Huntsville Item broke the news in on Wednesday, March 18, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Rahway icon

Rahway

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal